HomeProductsBuilding BlocksCarbocyclic ScaffoldsBenzene CompoundsLumateperone
Chemical structure of CAS 313368-91-1

Lumateperone

CAS No.313368-91-1
MDL No.MFCD28502161
MFC24H28FN3O
MW393.50
InChI KeyHOIIHACBCFLJET-SFTDATJTSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.313368-91-1
Product NameLumateperone

Biological Targets

DRD2·HTR2A·SLC6A4

Associated Conditions

major depressive disorder·schizophrenia·Borderline personality disorder·bipolar disorder·psychosis·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

An evaluation of lumateperone tosylate for the treatment of schizophrenia.

Expert opinion on pharmacotherapy • Vol. 21, Issue 2 • 2020
PMID: 31790322DOI: 10.1080/14656566.2019.1695778

Dopamine D receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • Vol. 44, Issue 3 • 2019
PMID: 30449883PMC: PMC6333832DOI: 10.1038/s41386-018-0251-1

Novel treatment options in depression and psychosis.

Neuropsychiatric disease and treatment • Vol. 14 • 2018
PMID: 29559781PMC: PMC5856289DOI: 10.2147/NDT.S157475

Lumateperone: a new treatment approach for neuropsychiatric disorders.

Drugs of today (Barcelona, Spain : 1998) • Vol. 54, Issue 12 • 2018
PMID: 30596390DOI: 10.1358/dot.2018.54.12.2899443

Documentation

Similar Products